Researchers reveal link between PCOS, type 2 diabetes August 29, 2017 | Women who have polycystic ovary syndrome (PCOS) have a higher risk of developing type 2 diabetes (T2D) and are diagnosed at an earlier age with the condition, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism…
Explore highlights of current education across the Endocrine Society.
How to Assess Second-Line Diabetes Agents for Patients at Risk for Major Osteoporotic Fractures
CME Activity | 0.5 AMA PRA Category 1 Credits™
Author: Doron Schneider, MD, FACP; Ann Schwartz, PhD, MPH
What are the best ways to help prevent your type 2 diabetes patient from avoiding major osteoporotic fractures? This interactive case study features can exploration of current science, clinical recommendations and medication options. The case study provides insights into mitigating fracture risk while effectively treating type 2 diabetes.
New Drugs in Diabetes – the Great Debate: How to Treat Type 2 Diabetes?
ENDO Session | No credit available
Faculty: David Nathan, MD and Daniel Drucker, MD
One of the most talked about sessions at ENDO 2017 was this much-anticipated debate. David Nathan, MD asks Are We Benefitting Anyone Other Than Pharma? while Daniel Drucker, MD sees True Innovation with Real Patient Benefits…
Can We Improve Cardiovascular Risk in Type 2 Diabetes?
ENDO Session | No credit available
Faculty: Cecilia C. Low Wang MD; Matthew Cavender, MD, MPH; Jennifer Green, MD; and William T. Cefalu, MD
Hear the latest about underlying mechanisms of cardiovascular disease and the impact of diabetes therapies in patients with diabetes.
Diabetes Diagnosis & Management 2017
Workshop Webcast | 7.5 AMA PRA Category 1 Credit™ and ABIM MOC Part 2 points
Planning Chairs: Johns (Jack) L. Leahy, MD and Carol H. Wysham, MD
Expert faculty provide state-of-the-art updates on cardiometabolic co-morbidities, new treatment options, and day-to-day strategies to manage patients with diabetes.
Best Practices for Type 2 Diabetes Management
Webcast | 1.0 AMA PRA Category 1 Credit™
Vivian A. Fonseca, MD, FRCP
Learn the best practices for the management of type 2 diabetes based on the latest guidelines and emerging treatment approaches.
Trial Updates in Type 2 Diabetes
CEU Satellite Symposium | 1.0 AMA PRA Category 1 Credit™
Carol H. Wysham, MD
Summarize cardiovascular complications and risk factors and integrate updated knowledge into practice, including the latest from the EMPA-REG and LEADER trials.
Diabetes @Point of Care
Practice Resource | Credit available
Find practical information when you need it the most to recognize signs, interpret results, and guide treatment decisions.
Transitions of Care: Type 1 Diabetes
Practice Resource | No credit available
Find resources for you and your patients to facilitate the challenging transition from pediatric to adult endocrine practice.
Systematic Characterization of Autophagy in Gestational Diabetes Mellitus Endocrinology | August 1, 2017 Lulu Ji, Zhiguo Chen, Yating Xu, Guoping Xiong, Rui Liu, Chao Wu, Hanyang Hu, and Lin Wang
Gestational diabetes mellitus (GDM) is a metabolic disease characterized by impaired glucose intolerance beginning, or first diagnosed, during pregnancy . According to the population studies, GDM can affect 3% to 30% of pregnant women. In addition, women with a pregnancy complicated…
Variation in Maturity-Onset Diabetes of the Young Genes Influence Response to Interventions for Diabetes Prevention JCEM | April 27, 2017 Liana K Billings, Kathleen A Jablonski, A Sofia Warner, Yu-Chien Cheng, Jarred B McAteer, Laura Tipton, Alan R Shuldiner, David A Ehrmann, Alisa K Manning, Dana Dabelea, Paul W Franks, Steven E Kahn, Toni I Pollin, William C Knowler, David Altshuler, and Jose C Florez for the Diabetes Prevention Program Research Group
Maturity-onset diabetes of the young (MODY) is characterized by a nonketotic form of diabetes mellitus transmitted by an autosomal dominant mode of inheritance that is usually diagnosed before the age of 25 years…
Biliary Anomalies in Patients With HNF1B Diabetes JCEM | March 17, 2017 Jarno L. T. Kettunen, Helka Parviainen, Päivi J. Miettinen, Martti Färkkilä, Marjo Tamminen, Pia Salonen, Eila Lantto, and Tiinamaija Tuomi
The clinical spectrum of organogenetic anomalies associated with HNF1B mutations is heterogeneous. Besides cystic kidney disease, diabetes, and various other manifestations, odd cases…
Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice Endocrinology | March 8, 2017 Aaron R. Cox, Carol J. Lam, Matthew M. Rankin, Jacqueline S. Rios, Julia Chavez, Claire W. Bonnyman, Kourtney B. King, Roger A. Wells, Deepti Anthony, Justin X. Tu, Jenny J. Kim, Changhong Li, and Jake A. Kushner
The impact of incretins upon pancreatic β-cell expansion remains extremely controversial. Multiple studies indicate that incretin-based therapies can increase…
Diabetes and Pregnancy JCEM | December 4, 2013 Ian Blumer, Eran Hadar, David R. Hadden, Lois Jovanovič, Jorge H. Mestman, M. Hassan Murad, and Yariv Yogev
Using an evidence-based approach, this Diabetes and Pregnancy Clinical Practice Guideline addresses important clinical issues in the contemporary management of women with type 1 or type 2 diabetes…
Management of Hyperglycemia in Hospitalized Patients in Non-critical Care Setting JCEM | July 2, 2013 Guillermo E. Umpierrez, Richard Hellman, Mary T. Korytkowski, Mikhail Kosiborod, Gregory A. Maynard, Victor M. Montori, Jane J. Seley, and Greet Van den Berghe
Hyperglycemia is a common, serious, and costly health care problem in hospitalized patients. Observational and randomized controlled studies indicate that improvement in glycemic control results…
Evaluation and Management of Adult Hypoglycemic Disorders JCEM | April 30, 2011 Philip E. Cryer, Lloyd Axelrod, Ashley B. Grossman, Simon R. Heller, Victor M. Montori, Elizabeth R. Seaquist, and F. John Service
We recommend evaluation and management of hypoglycemia only in patients in whom Whipple's triad--symptoms, signs, or both consistent with hypoglycemia, a low plasma glucose concentration, and…
ENDO 2018 Dates: March 17–20, 2018 Location: Chicago, Illinois, United States Sponsor: Endocrine Society
ENDO is the world’s largest event for presenting and obtaining the latest in endocrine science and medicine with an extensive program covering a broad array of topics, various networking opportunities, poster sessions, updates on new products and technologies at the ENDOExpo, and more.